Member Info for JustHereForHemo

MASSIVE thanks for this goes out to Haywain and Pingu, ALOT of effort has been going on behind the scenes to tell ALOT of very professional people about Hemogenyx. I am not exaggerating when I say people are excited, not traders not unicorn chasers. But doctors, lawyers, accountants, people who buy indexes though their brokers and pay by cheque. Many many hours have been spent just canvasing and telling people about Hemogenyx so they can do their own research and make their own decisions. Many many many hours.... Sooooo many hours....

The share price before was fake.

It was unsustainable.

Its still pathetic at just over 1p old money and we have a VERY VERY long way to go before fair price. Is it enough for a Pizza oven? Sure. But FAIR market price for Hemogenyx is many many multiples of here.

Hulver, at that time the cost of manufacturing was around £400k per month with only like one patient per month, with the cutting of most of the staff, sublease of lab, move to G-Rex etc he can run the trial at less than £250k now and he just raised 570k so we are looking good :-)

Jesus wept....

The spread at time of the trade was 350.00 -> 360.00 with multiple buys at the same time +- 2 mins all lower.

It was a buy.

My dog knows it was a buy, idiot laughy face knows it was a buy.

"Looking at trades at that time would say a Sell" - Looking at a post like that would say you have sold out and taken your 10%, well done you, rush back to your ROQ, you were telling us all a deal is guaranteed by 31st!

Reasons why I invested in Hemogenyx:

I want to feel good about my investment

I believed Hemogenyx would save lives which it has

I believed Hemogenyx was massively undervalued and will make me a very healthy profit - I am more convinced than ever.

Not reasons I Invested in Hemogenyx:

To fight with people.

Seriously enough is enough, block each other and talk about Hemogenyx, we are at such an exciting inflection point here and we can see whats happening and where its going, many of us just dont care about what other posters have said or done, the past belongs in the past.

To be clear, though, I can only speak for those in the recent placing, the previous people? IF they could convert I am sure many of them would, but as far as I know they need a prospectus

Sorry that was a low blow!

But this is not something new, its the reason the company had to use the directors workaround to even do a placing. They have no headroom, a warrant is a right to buy a "new" share at a given price. The company HAVE to have the authority to do so, the 20% rule is rolling, so november at the earliest 250k shares, IF someone really wants to convert.

Ill be brutally honest..... I have no intention of converting, as others have pointed out IF Hemogenyx does licence for 1bn+ and I sold out for a few k??? My kids would disown me. Hemogenyx is a chance at generational wealth and the idea of selling share or warrants down here is just bonkers.

I get it, plenty of people ONLY trade and 10-15% is good for them

Plenty of others just think I am full of hot air and dont believe me, fine.

I believe it, everyone in the recent placing believes it. We bought the share and warrants for a change of ownership event, not to flip for 100% profit.

Its common sense, its also written on the terms and conditions of the warrants that were issued, I will gladly paste the full section here IF you would be so kind as to post the details of the CLN from AVCT that details the quarterly price discount formula.... :P

If the SP is up sufficently and the company agree they could do a prospectus, but warrant holders cannot force the company to do so.

Holders are only allowed to execute the warrants if the company have headroom to do so. There will be SOME headroom 11th November for like 250k shares, but then yes the rest are locked until feb and the rolling 20% reset

It's a beautiful day and the sky is blue, why waste it arguing?

This is an exciting period, we are past day 14. Onwards and upwards!

It's incredibly rare for someone to say that and still have the decency to wish everyone well.

Thank you, it's worth calling out chivalry, I wish you every success in what you do ❤️

No leaks, day 14 for p3, no news is good news.

In addition... a wide pool of new investors have suddenly discovered Hemogenyx and they are not traders.

It took a while but we have started the road to recovery, long way to go but it's started. Yes this rise is sustainable and yes I predict alot higher.

A lot of pharma went bust in the last 12 months. Bio tanked and anyone dependant on NIH grants got destroyed. Pharma will recover and with massive patent cliffs approaching anyone with new IP should do well. Last 24 months has been a battle of survival.

We survived.

A JV or licencing deal would likely just mean a large cash injection but no the company would remain listed.

A takeover would mean we are bought out, given cash and that it our journey ends.

There are other possibilities at this point though aswell, Vlad was talking about subletting the lab and grants etc may be possible, IF that is an option then retaining 100% ownership could happen..... COULD... atleast for a while. Its really worth highlighting that Hemogenyx have undergone significant "re-modelling" they now burn less than 250k and are able to sustain the trails due to the flip to G-REX.

Anyone here reading this would be well advised to just ignore this board and go and ask AI to read the RNS's, analyse the pipeline and tell you what its worth.

Will put a bit of a sensible post here, for the "new" vistitors, just so you understand this is not a pump and dump, Hemogenyx underwent more of a poop and scoop. Its been pushed down hard from a 70m mCap to 7m despite ALOT of very positive news, often falling harder when news was good.

It has been low exposure, low volume, no interest allowing the SP to basically be forced towards zero.

Today has been nothing more than a small partial recovery but we are back to where we were before patient 1 was injected and no more.

IF HG-CT-1 continues to work as it appears to be doing thus far then its worth 100s of millions if not a billion+ in the very near future, a JV or licencing deal is more likely than not in the coming months. The share price was completely disconnected from the value.

Traders chasing percentages will try and cross ramp you to case rainbows and unicorns trying to say that all small pharma are the same and will do the same percentages....

That's categorically false.

The starting mCap is important, a company with an mCap of 10m can bag MUCH easier than a company at 200m, its simple maths.

Companies with huge debt just will never do the same until that debt is gone

When people cross ramp on promises of a deal? If the market knows about the deal then its priced in and probably not that good and delayed with very little cash attached.

If your here now dont be lazy. Do some actual research. We have 3 patients treated in cohort 1 who had rr AML, a death sentence, none have had HSCT and so far no reported adverse affects. Go check what that is worth.

Dont forget to look at finances, they have reduced headcount by over half, they got a grant to move from cocoon to G-REX which massively reduces the cost of CAR-T manufacturing and allows parallel manufacturing.

Most importantly? The company recently got permission to start treating children. In the coming weeks or maybe months the first child will be chosen for HG-CT-1, and I am sure EVERYONE here is looking forward to that milestone.

Hemogenyx is not a meme stock, they are not a pump and dump, they are not a lottery ticket. They are a massively undervalued pharma that have suffered years of manipulation but have managed to survive to clinical trials and so far appear to have created a curative CAR-T for FLT3 AML.

Challenge to you. Take my post, all of it, stick it in AI and ask am I telling the truth.

Oh at £6 a share, sure have at it provided its a premium :-)

Absolutely not, because the second you go down that road the SP tanks.

Dont worry about Vlad or Hemogenyx, we have this.

The company cash burn is under 250k a month and the investor pool now standing behind Hemogenyx are standing shoulder to shoulder. The brokers can go and suck weiner.

The Zealot Army are here and we are not going anywhere, and Vlad knows that. More importantly the market now knows it too.

You do realise that your ROQ BoD confirmed no deal is coming in August, maybe by end of year, you saw that right?

ROQ director confirmed no deal this month. Go read the posts.